Welcome to our dedicated page for Fuller H B Co SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The H.B. Fuller Company (NYSE: FUL) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret them. H.B. Fuller is a Minnesota-based issuer that describes itself as the largest pureplay adhesives company in the world, focused on adhesives, sealants, functional coatings and other chemical-based products.
Investors can use this page to access current and historical Forms 8‑K, which H.B. Fuller files to report material events such as quarterly and annual earnings releases, dividend declarations and board changes. Recent 8‑K filings referenced in the input include items under Item 2.02 – Results of Operations and Financial Condition and Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers, along with exhibits that attach the related press releases.
In addition to event-driven reports, users can review the company’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q (when available in the feed). These filings typically provide detailed information on net revenue, margins, net income, cash flow, segment performance, risk factors and other disclosures that complement the non‑GAAP metrics discussed in earnings releases and Regulation G reconciliation tables.
Stock Titan’s platform enhances these documents with AI-powered summaries that explain key sections of lengthy filings, highlight important changes from prior periods and clarify technical language. Real-time updates from EDGAR ensure that new H.B. Fuller filings appear promptly, while links to exhibits make it easier to connect narrative disclosures with supporting press releases and financial tables.
For users researching FUL, this page offers a focused view of H.B. Fuller’s regulatory history, from material event 8‑Ks to periodic reports, helping readers understand how the adhesives manufacturer describes its operations, financial condition, governance and risk profile in formal SEC documents.
H.B. Fuller Executive VP and CFO John J. Corkrean received a grant of 232.280 Phantom Units on 2026-03-13, reported at a transaction price of $54.2600 per unit. These units convert into common stock on a 1-for-1 basis under the company’s deferred compensation plan.
Following this grant, his Phantom Unit balance is 32,844.280 units. He also directly holds 59,508 shares of common stock, along with multiple employee stock options and restricted stock unit awards with various exercise prices and vesting schedules.
FULLER H B CO senior vice president of international growth Heather Campe received a grant of 41.06 Phantom Units on 2026-03-13 under a compensation plan. The grant is recorded at a reference price of $54.26 per unit and converts into common stock on a 1-for-1 basis.
After this award, Campe directly holds 5,460.64 Phantom Units, 24,653.0782 shares of common stock, and multiple employee stock options and restricted stock units on common stock with exercise prices ranging from $51.89 to $77.72 and expirations between 2028 and 2036.
H.B. Fuller is asking shareholders to vote at its virtual 2026 Annual Meeting on April 16, 2026, on three main items: re‑electing three Class III directors to terms running to 2029, ratifying Ernst & Young LLP as auditor for fiscal 2026, and approving a non‑binding advisory say‑on‑pay proposal.
The company highlights 2025 results including net revenue of $3.47 billion, net income of $152 million, EPS of $2.75 (adjusted EPS of $4.24), adjusted EBITDA of $621 million, and a record adjusted EBITDA margin of 17.9%. It also increased its quarterly dividend for the 56th consecutive year, up 5.6%.
The proxy emphasizes pay‑for‑performance: short‑term incentive payouts for top executives were around 99% of target based on adjusted EPS, revenue, EBITDA, and margin metrics, while 25% of equity awards are performance stock units tied to three‑year ROIC. The Board reports 89% independence, 56% women, and an average tenure of 5.44 years.
FULLER H B CO Executive VP and CFO John J. Corkrean reported an equity-based compensation grant. On February 27, 2026, he acquired 191.78 Phantom Units at $65.72 per unit as a grant, not an open-market purchase.
According to footnotes, these phantom units convert into common stock on a 1-for-1 basis, generally upon certain termination events or an earlier date selected under the Key Employee Deferred Compensation Plan, subject to legal holding periods. After this grant, Corkrean held 32,612 Phantom Units.
The filing also updates direct holdings of various employee stock options, restricted stock units that vest in three annual installments of 33%, 33%, and 34%, and direct common stock holdings, reflecting his overall equity-based compensation position in the company.
H.B. Fuller senior vice president Heather Campe reported an equity award and updated her equity holdings. On February 27, 2026, she acquired 33.9000 Phantom Units at a reference price of $65.7200 per unit as a grant, bringing her total Phantom Units to 5419.5800. Footnotes indicate these units convert into common stock on a 1-for-1 basis under the company’s deferred compensation plan, with dividend equivalents reinvested in additional units. The filing also lists her direct holdings of employee stock options, restricted stock units that vest over three annual installments, and 24653.0782 shares of common stock, giving a snapshot of her overall long-term incentive position.
FULLER H B CO director Teresa J. Rasmussen Trangsrud reported an acquisition of stock units under a compensation plan. On February 27, 2026, she received 1,004.2600 stock units at an assigned value of $65.7200 per unit, increasing her stock unit balance to 20,839.9500 units.
The stock units convert into an equal number of common shares on a 1-for-1 basis after retirement, death, disability, or other specified events, subject to legal holding periods. Her directly held common stock position was reported at 2,386.5580 shares, which includes shares and stock units accumulated through dividend reinvestment and dividend equivalent features of a directors' deferred compensation plan.
FULLER H B CO director Charles T. Lauber received a grant of 147.14 stock units on common stock. The units were valued at $65.72 per unit and increase his directly held stock unit balance to 10,179.79 units.
These stock units convert into shares of common stock on a 1-for-1 basis and will be converted upon retirement, death, disability or other specified events under the Directors' Deferred Compensation Plan, subject to legal holding periods. The filing also shows he directly holds 1,351 shares of common stock.
FULLER H B CO director Ruth Kimmelshue reported an award of 502.1300 stock units on February 27, 2026 at $65.7200 per unit. These stock units convert into common stock on a 1-for-1 basis under the Directors' Deferred Compensation Plan.
The units will be converted into shares of common stock upon retirement, death, disability or certain specified events, subject to required holding periods. After this award, Kimmelshue holds 33,361.8200 stock units and 1,351.0000 shares of common stock directly.
FULLER H B CO director Michael J. Happe received a grant of 418.4400 stock units on 2026-02-27 as a grant, award, or other acquisition valued at $65.7200 per unit. These stock units convert into common shares on a 1-for-1 basis upon retirement, death, disability, or other specified events under the Directors' Deferred Compensation Plan. Following this award, Happe directly holds 14385.9100 stock units and 1343.0000 common shares.